Cargando…
Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias
Polyglutamine spinocerebellar ataxias (PolyQ SCAs) are a group of 6 rare autosomal dominant diseases, which arise from an abnormal CAG repeat expansion in the coding region of their causative gene. These neurodegenerative ataxic disorders are characterized by progressive cerebellar degeneration, whi...
Autores principales: | Afonso-Reis, Ricardo, Afonso, Inês T., Nóbrega, Clévio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074016/ https://www.ncbi.nlm.nih.gov/pubmed/33921915 http://dx.doi.org/10.3390/ijms22084249 |
Ejemplares similares
-
Functional implications of paralog genes in polyglutamine spinocerebellar ataxias
por: Felício, Daniela, et al.
Publicado: (2023) -
Mutant Ataxin-2 Expression in Aged Animals Aggravates Neuropathological Features Associated with Spinocerebellar Ataxia Type 2
por: Afonso, Inês T., et al.
Publicado: (2022) -
Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy
por: Marcelo, Adriana, et al.
Publicado: (2021) -
Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics
por: Paulino, Rodrigo, et al.
Publicado: (2023) -
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019)